Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasms, Unknown Primary × Albumin-Bound Paclitaxel × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 65 Pancreatic Neoplasms 47 Carcinoma, Non-Small-Cell Lung 28 Triple Negative Breast Neoplasms 24 Neoplasm Metastasis 14 Squamous Cell Carcinoma of Head and Neck 13 Ovarian Neoplasms 11 Lung Neoplasms 10 Esophageal Neoplasms 10 Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Stomach Neoplasms 8 Melanoma 7 Uterine Cervical Neoplasms 6 Head and Neck Neoplasms 6 Cholangiocarcinoma 6 Small Cell Lung Carcinoma 5 Recurrence 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Adenocarcinoma 4 Inflammatory Breast Neoplasms 4 Advanced Pancreatic Cancer 4 Sarcoma 3 Colorectal Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Breast Neoplasms, Male 3 Adenocarcinoma 3 Uveal Melanoma 2

Interventions

Gemcitabine 8 Carboplatin 8 Paclitaxel 6 Capecitabine 4 Irinotecan 3 Bevacizumab 3 pembrolizumab 2 atezolizumab 2 Peripheral Blood Stem Cell Transplantation 2 Oxaliplatin 2 Filgrastim 2 Erlotinib Hydrochloride 2 Cisplatin 2 CP protocol 2 tegafur-gimeracil-oteracil 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 etoposide phosphate 1 entrectinib 1 cobimetinib 1 belinostat 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alectinib 1 Vemurafenib 1 Transurethral Resection of Prostate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02607202 2024-01-26

AGNOSTOS

Fondazione del Piemonte per l'Oncologia

Phase 2 Completed

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡